Vermillion Inc.
|
 | ||||||||||
|
 |
  |
 |
|
|
||
 |
 |
|
|
|
|
|
||
|
|
 
 |
return to message board, top of board |
patent allowance $2.05 on newsVermillion receives notice of allowance for patent 'Biomarkers for Ovarian Cancer' (VRML) 1.90 : The patent makes claims in the uses of a urinary Small MBL-associated protein C-terminal fragment in the diagnosis of ovarian cancer, ovarian cancer monitoring, and patient management.
|
|
|
return to message board, top of board |
